Tag: Durvalumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Durvalumab

Fifth Third Bancorp Increases Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Added to Collection on: 2023-01-10 21:59:34

Tags for this article:

Economy
Companies
Financial markets
AstraZeneca
Södertälje Municipality
Monoclonal antibodies
Short
AZN
Stock market
Zeneca
Stock
Durvalumab
Fifth Third Bancorp
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
AstraZeneca PLC (LON:AZN) Receives Consensus Rating of "Moderate Buy" from Analysts

Added to Collection on: 2023-01-11 06:22:23

Tags for this article:

Economy
Companies
Finance
AstraZeneca
Södertälje Municipality
Monoclonal antibodies
AZN
Short
Durvalumab
Financial analyst
Price?earnings ratio
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
Datopotamab Deruxtecan Plus Durvalumab Showed Promising Clinical Activity in the First ...

Added to Collection on: 2023-09-11 13:58:46

Tags for this article:

Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Lung cancer
Cancer treatments
Trastuzumab deruxtecan
Durvalumab
Treatment of lung cancer
Daiichi Sankyo
Non-small-cell lung cancer
Checkpoint inhibitor
Pembrolizumab
TROPION
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Adding Durvalumab and Olaparib to Chemo Improves PFS in Endometrial Cancer

Added to Collection on: 2023-10-21 21:32:19

Tags for this article:

Orphan drugs
Breakthrough therapy
Monoclonal antibodies
Antineoplastic drugs
Durvalumab
Lactams
Olaparib
PARP inhibitor
Progression-free survival
Carboplatin
Paclitaxel

Click the tags to see associated articles and topics

View Article Details
Durvalumab by AstraZeneca for Esophageal Cancer: Likelihood of Approval

Added to Collection on: 2023-10-27 22:10:03

Tags for this article:

Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Oncology
Squamous-cell carcinoma
Durvalumab
Neprilysin
Chemotherapy regimen
Thyroid neoplasm
Bladder cancer
Transitional cell carcinoma
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi ...

Added to Collection on: 2023-10-28 16:14:08

Tags for this article:

Antineoplastic drugs
Orphan drugs
Breakthrough therapy
Cancer treatments
Cancer immunotherapy
TIGIT
Checkpoint inhibitor
Chemotherapy
Enteropathy-associated T-cell lymphoma
Treatment of lung cancer
Durvalumab
Shanghai
Gemcitabine
shanghai junshi biosciences co., ltd.
Coherus Biosciences Inc.
United States
China
Cisplatin
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi Phase III trial raises trial design questions - Clinical Trials Arena

Added to Collection on: 2023-11-21 16:30:12

Tags for this article:

Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Immune system
Durvalumab
Checkpoint inhibitor
Pembrolizumab
Nivolumab
TIGIT
Non-small-cell lung cancer
PD-L1
Imfinzi

Click the tags to see associated articles and topics

View Article Details
Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical Cancer

Added to Collection on: 2024-01-06 04:39:44

Tags for this article:

Orphan drugs
Atezolizumab
Bevacizumab
Survival rate
TIGIT
Durvalumab

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi combination shows promise in phase 3 liver cancer study - PMLiVE

Added to Collection on: 2024-01-23 13:43:45

Tags for this article:

Orphan drugs
Hepatology
Monoclonal antibodies
Infectious causes of cancer
Durvalumab
Hepatocellular carcinoma
Progression-free survival
Liver cancer
Tremelimumab
Bevacizumab
Clinical endpoint
Bland embolization
Avastin
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi shows benefits in endometrial cancer trial

Added to Collection on: 2024-03-19 17:32:10

Tags for this article:

Orphan drugs
Cancer immunotherapy
Antineoplastic drugs
Monoclonal antibodies
Durvalumab
Checkpoint inhibitor
Endometrial cancer
Olaparib
Clinical endpoint
AstraZeneca

Click the tags to see associated articles and topics

View Article Details